Penumbra Stock Hits 52-Week High at $277.89 Amid Growth Optimism By Investing.com
Penumbra Inc . (NYSE:), a global healthcare company valued at $10.6 billion, has reached a new 52-week high, with its stock price soaring to $277.89. According to InvestingPro analysis, the company maintains a “GREAT” financial health score, though current valuations suggest the stock may be trading above its Fair Value. This peak reflects a significant […]
Penumbra Stock Hits 52-Week High at $277.89 Amid Growth Optimism By Investing.com Read More »